U.S. federal trademark · Serial No. 90309462 · Reg. No. 6604225
Providing medical diagnostic testing services to dermatologists, surgeons, and oncologists for diagnostic and prognostic purposes for dermatologic melanoma, namely genetic expression profiling and gene sequencing using a neural network, artificial intelligence-designed algorithm relating to dermatological melanoma, and providing medical information based on the expression
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.